| HOME >> MEDICINE >> TECHNOLOGY |
7 Bone Metastases Therapeutics: Strategic Assessment 51
7.1 Key Events Impacting the Future Market 51
7.2 Bone Metastases Therapeutics: Implications for Future Market Competition 52
8 Bone Metastases Therapeutics: Future Players 53
8.1 Introduction 53
8.2 Company Profiles 54
8.2.1 Novartis AG 54
8.2.2 Amgen Inc. 60
8.2.3 Bayer AG 63
8.2.4 Algeta ASA 67
8.2.5 Merrion Pharmaceuticals Plc 69
8.2.6 Other Companies in the Bone Metastases Therapeutics Market 70
9 Bone Metastases Therapeutics: Licensing and Partnership Deals 72
10 Bone Metastases Therapeutics: Appendix 76
10.1 Market Definitions 76
10.2 Abbreviations 76
10.3 Research Methodology 77
10.3.1 Coverage 77
10.3.2 Secondary Research 77
10.3.3 Forecasting 78
10.3.4 Primary Research 80
10.3.5 Expert Panel Validation 80
10.4 Contact Us 80
10.5 Disclaimer 80
10.6 Bibliography 81
1.1 List of Tables
Table 1: Metastatic Bone Disease is Prevalent in Many Types of Cancer 6
Table 2: Prevalence of Bone Metastases in Different Cancer Types, 2010 7
Table 3: Bone Metastases Therapeutics Market, Global, Revenue ($m), 2005–2010 16
Table 4: Bone Metastases Therapeutics Market, Global, Forecast ($m), 2010–2017 17
Table 5: Bone Metastases Therapeutics Market, France, Revenue ($m), 2005–2010 20
Table 6: Bone Metastases Therapeutics Market, France, Forecasts ($m), 2010–2017 21
Table 7: Bone Metastases Therapeutics Market, Germany, Revenue ($m), 2005–2010 22
Table 8: Bone Metastases Therapeutics Market, Germany, Forecasts ($m), 2010–2017 23
Table 9: Bone Metastases Therapeutics Market, Italy, Revenue ($m), 2005–2010 24
Table 10: Bone Metastases Therapeutics Market, Italy, Forecasts ($m), 2010–2017 25
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |